Biogen Inc.

MA 2022 Independent Pharmacies

DOJ False Claims Act Anti Kickback

Penalty

$900 million

Outcome

Biogen Inc. Agrees to Pay $900 Million to Settle False Claims Act Allegations Related to Improper Physician Payments

Details

Biogen Inc. — DOJ Enforcement (2022)

DOJ took enforcement action against Biogen Inc. in MA in 2022 involving false claims act, anti kickback violations in the Independent Pharmacies sector.

Penalty: $900 million

Violation types: False Claims Act, Anti Kickback
Entity type: Pharmacy
Penalty type: Settlement
Location: MA

Source: DOJ Press Release — Biogen Inc. Agrees to Pay $900 Million to Settle False Claims Act Allegations Related to Improper Physician Payments

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted. Crucible monitors referral patterns and financial arrangements to flag potential anti-kickback violations.

Source: DOJ Press Release — Biogen Inc. Agrees to Pay $900 Million to Settle False Claims Act Allegations Related to Improper Physician Payments

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works